ArticlePharmaceuticals (Basel, Switzerland)2024

Functional Progression after Dose Suspension or Discontinuation of Nintedanib in Idiopathic Pulmonary Fibrosis: A Real-Life Multicentre Study.

Barbara Ruaro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.